Advertisement

Topics

Two Sigma Investments LP Takes Position in Achillion Pharmaceuticals, Inc.

20:27 EDT 28 Mar 2018 | Topix

Two Sigma Investments LP acquired a new position in shares of Achillion Pharmaceuticals, Inc. during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,107,595 shares of the biopharmaceutical company's stock, valued at approximately $3,190,000.

Original Article: Two Sigma Investments LP Takes Position in Achillion Pharmaceuticals, Inc.

NEXT ARTICLE

More From BioPortfolio on "Two Sigma Investments LP Takes Position in Achillion Pharmaceuticals, Inc."

Advertisement
Quick Search
Advertisement
Advertisement